Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Longhurst

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Allergy|January 21, 2014
Open-label, multicenter study of self-administered icatibant for attacks of hereditary angioedemaW Aberer, M Maurer, A Reshef, et al.
Annals of the Rheumatic Diseases|October 2, 2014
Pegylated interferon-α-2b reduces corticosteroid requirement in patients with Behçet's disease with upregulation of circulating regulatory T cells and reduction of Th17S Lightman, S R J Taylor, C Bunce, et al.
Clinical and Experimental Immunology|July 15, 2017
Screening protocols to monitor respiratory status in primary immunodeficiency disease: findings from a European survey and subclinical infection working groupS Jolles, S Sánchez-Ramón, I Quinti, et al.
Clinical and Experimental Immunology|June 22, 2013
A UK national audit of hereditary and acquired angioedemaS Jolles, P Williams, E Carne, et al.
Allergy|January 11, 2018
The international WAO/EAACI guideline for the management of hereditary angioedema-The 2017 revision and updateM Maurer, M Magerl, I Ansotegui, et al.
Allergy|April 25, 2018
Evaluation of avoralstat, an oral kallikrein inhibitor, in a Phase 3 hereditary angioedema prophylaxis trial: The OPuS-2 studyM A Riedl, E Aygören-Pürsün, J Baker, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Allergy|January 21, 2014
Open-label, multicenter study of self-administered icatibant for attacks of hereditary angioedemaW Aberer, M Maurer, A Reshef, et al.
Annals of the Rheumatic Diseases|October 2, 2014
Pegylated interferon-α-2b reduces corticosteroid requirement in patients with Behçet's disease with upregulation of circulating regulatory T cells and reduction of Th17S Lightman, S R J Taylor, C Bunce, et al.
Clinical and Experimental Immunology|July 15, 2017
Screening protocols to monitor respiratory status in primary immunodeficiency disease: findings from a European survey and subclinical infection working groupS Jolles, S Sánchez-Ramón, I Quinti, et al.
Clinical and Experimental Immunology|June 22, 2013
A UK national audit of hereditary and acquired angioedemaS Jolles, P Williams, E Carne, et al.
Allergy|January 11, 2018
The international WAO/EAACI guideline for the management of hereditary angioedema-The 2017 revision and updateM Maurer, M Magerl, I Ansotegui, et al.
Allergy|April 25, 2018
Evaluation of avoralstat, an oral kallikrein inhibitor, in a Phase 3 hereditary angioedema prophylaxis trial: The OPuS-2 studyM A Riedl, E Aygören-Pürsün, J Baker, et al.
Pageof 2